Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

Yamanaka, Koji, Chun, Seung Joo, Boillee, Severine, Fujimori-Tonou, Noriko, Yamashita, Hirofumi, Gutmann, David H, Takahashi, Ryosuke, Misawa, Hidemi +1 more·2008·Nature Neuroscience

Cited by (1,000)

Items 601–700 of 1,000

  1. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration
    Nina Vardjan, Alexei Verkhratsky, Robert Zorec · 2017 · International Journal of Molecular Sciences
  2. Phenotypic heterogeneity of astrocytes in motor neuron disease
    Emiliano Trías, Luis Barbeito, Koji Yamanaka · 2018 · Clinical and Experimental Neuroimmunology
  3. Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis
    Eiichi Tokuda, Shunsuke Watanabe, Eriko Okawa, Shin-ichi Ono · 2015 · Neurotherapeutics
  4. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis
    Wint Nandar, Elizabeth B. Neely, Zachary Simmons, James R. Connor · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  5. Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
    Eiichiro Nagata, Mieko Ogino, Kounosuke Iwamoto, Yasuhisa Kitagawa, Yasuo Iwasaki, Fumihito Yoshii, Joh‐E Ikeda · 2016 · PLoS ONE
  6. Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease
    Robert I. Richards, Sarah Anne Robertson, Daniel L. Kastner · 2018 · Human Molecular Genetics
  7. Optogenetic manipulation of astrocytes from synapses to neuronal networks: A potential therapeutic strategy for neurodegenerative diseases
    Zhen Xie, Qinghu Yang, Da Feng Song, Zhenzhen Quan, Hong Qing · 2019 · Glia
  8. The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis
    Christoph Schweingruber, Eva Hedlund · 2022 · Biology
  9. A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model
    Kazunori Tanaka, Takuya Kanno, Yoshiko Yanagisawa, Kaori Yasutake, Satoshi Inoue, N. Hirayama, Joh‐E Ikeda · 2014 · PLoS ONE
  10. Noradrenergic regulation of period1 expression in spinal astrocytes is involved in protein kinase A, c-Jun N-terminal kinase and extracellular signal-regulated kinase activation mediated by α1- and β2-adrenoceptors
    Tatsuhiko Sugimoto, Norimitsu Morioka, K. Sato, Kazue Hisaoka, Yoshihiro Nakata · 2011 · Neuroscience
  11. New In Vitro Models to Study Amyotrophic Lateral Sclerosis
    Monika A. Myszczynska, L. Ferraiuolo · 2016 · Brain Pathology
  12. Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation
    Marcie Jiménez, Pablo Díaz‐Amarilla, Eugenia Isasi, Gabriela Casanova, Luis Barbeito, Silvia Olivera‐Bravo · 2017 · Cell and Tissue Research
  13. Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models
    Takuya Tamura, Masaki Sone, Mayumi Yamashita, Erich E. Wanker, Hitoshi Okazawa · 2009 · PLoS ONE
  14. Selective vulnerability of motor neuron types and functional groups to degeneration in amyotrophic lateral sclerosis: review of the neurobiological mechanisms and functional correlates
    Saak Victor Ovsepian, Valerie B. O’Leary, Salvador Martı́nez · 2023 · Brain Structure and Function
  15. Links between Electrophysiological and Molecular Pathology of Amyotrophic Lateral Sclerosis
    Katharina A. Quinlan · 2011 · Integrative and Comparative Biology
  16. The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening
    David M. Gonzalez, Jill K. Gregory, Kristen Brennand · 2017 · Frontiers in Cell and Developmental Biology
  17. A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model
    Naomi Tsuburaya, Kengo Homma, Tsunehiko Higuchi, Andrii G. Balia, Hiroyuki Yamakoshi, Norio Shibata, Seiichi Nakamura, Hidehiko Nakagawa, S Ikeda, Naoki Umezawa et al. · 2018 · Nature Communications
  18. Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
    Chia‐Chi Hung, Yi‐Hsuan Lee, Yi-Min Kuo, Pei-Chien Hsu, Huey-Jen Tsay, Ying-Ting Hsu, Chih-Chin Lee, Jia-Jun Liang, Feng‐Shiun Shie · 2019 · Journal of Neuroinflammation
  19. Genetic targeting of astrocytes to combat neurodegenerative disease
    GregoryW Kirschen, Rachel Kéry, AllenP. F. Chen · 2019 · Neural Regeneration Research
  20. Translatomic analysis of regenerating and degenerating spinal motor neurons in injury and ALS
    Jennifer L. Shadrach, Wesley M. Stansberry, Allison M. Milen, Rachel E. Ives, Elizabeth A. Fogarty, Anthony Antonellis, Brian A. Pierchala · 2021 · iScience
  21. Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS
    Elisabetta Carata, Marco Muci, Simona Di Giulio, Stefania Mariano, Elisa Panzarini · 2023 · International Journal of Molecular Sciences
  22. Quantitative studies of lower motor neuron degeneration in amyotrophic lateral sclerosis: Evidence for exponential decay of motor unit numbers and greatest rate of loss at the site of onset
    Fusun Baumann, Robert D. Henderson, Gareth Ridall, Anthony N. Pettitt, Pamela McCombe · 2012 · Clinical Neurophysiology
  23. Novel Molecular Biomarkers at the Blood-Brain Barrier in ALS
    Danijela Bataveljić, Milena M. Milosevic, Lidija Radenović, Pavle R. Anđjus · 2014 · BioMed Research International
  24. The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease
    Jinbin Zhai, W. Zhou, J. Li, Christopher R. Hayworth, L. Zhang, Hidemi Misawa, Rüdiger Klein, Steven S. Scherer, Rita J. Balice‐Gordon, Robert Gordon Kalb · 2011 · Human Molecular Genetics
  25. Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs
    Madeline Halpern, Kristen Brennand, James A. Gregory · 2019 · Neurobiology of Disease
  26. RNA quality control and protein aggregates in amyotrophic lateral sclerosis: A review
    Ashok K. Verma, Rup Tandan · 2012 · Muscle & Nerve
  27. Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model
    Chen Benkler, Yael Barhum, Tali Ben‐Zur, Daniel Offen · 2015 · Journal of Molecular Neuroscience
  28. Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression
    Tiziana Bonifacino, Claudia Rebosio, Francesca Provenzano, Carola Torazza, Matilde Balbi, Marco Milanese, Luca Raiteri, Cesare Usai, Ernesto Fedele, Giambattista Bonanno · 2019 · International Journal of Molecular Sciences
  29. Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation
    Jae‐Hong Kim, Md. Habibur Rahman, Donghwi Park, Myungjin Jo, Hyung-Jun Kim, Kyoungho Suk · 2021 · Cells
  30. Apoptosis‐Inducing Factor and Cyclophilin A Cotranslocate to the Motor Neuronal Nuclei in Amyotrophic Lateral Sclerosis Model Mice
    Hirotaka Tanaka, Hiroki Shimazaki, Masataka Kimura, Hiroshi Izuta, Kazuhiro Tsuruma, Masamitsu Shimazawa, Hideaki Hara · 2010 · CNS Neuroscience & Therapeutics
  31. Neurotoxic Species of Misfolded SOD1G93ARecognized by Antibodies Against the P2X4Subunit of the ATP Receptor Accumulate in Damaged Neurons of Transgenic Animal Models of Amyotrophic Lateral Sclerosis
    Sara Hernández, Anna Casanovas, Lídia Piedrafita, Olga Tarabal, Josep Enric Esquerda · 2010 · Journal of Neuropathology & Experimental Neurology
  32. The phosphorylation status and cytoskeletal remodeling of striatal astrocytes treated with quinolinic acid
    Paula Pierozan, Fernanda da Silva Ferreira, Bárbara Ortiz de Lima, Carolina Gonçalves Fernandes, Priscila Totarelli Monteforte, Natalia de Castro Medaglia, Cláudia Bincoletto, Soraya Soubhi Smaili, Regina Pessoa‐Pureur · 2014 · Experimental Cell Research
  33. Gene, Cell, and Axon Changes in the Familial Amyotrophic Lateral Sclerosis Mouse Sensorimotor Cortex
    Roman Kassa, Raffaella Mariotti, Marta Bonaconsa, Giuseppe Bertini, Marina Bentivoglio · 2008 · Journal of Neuropathology & Experimental Neurology
  34. Glia: an emerging target for neurological disease therapy
    Akshata A Almad, Nicholas John Maragakis · 2012 · Stem Cell Research & Therapy
  35. Systems biology analysis of Drosophila in vivo screen data elucidates core networks for DNA damage repair in SCA1.
    Sam Barclay, T. Tamura, Hikaru Ito, Kyota Fujita, K. Tagawa, T. Shimamura, Asuka Katsuta, Hiroki Shiwaku, M. Sone, S. Imoto et al. · 2014 · Human Molecular Genetics
  36. Accumulation and aggregate formation of mutant superoxide dismutase 1 in canine degenerative myelopathy
    Sayuri Nakamae, Yui Kobatake, R Suzuki, Toshihiro Tsukui, Shinsuke Kato, Osamu Yamato, H. Sakai, Makoto Urushitani, Sadatohi Maeda, Hiroaki Kamishina · 2015 · Neuroscience
  37. Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
    Hansen Wang, Laurie C. Doering · 2012 · Neural Plasticity
  38. Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75 NTR and RAGE Signaling in ALS
    Mi Jin Kim, Marcelo R. Vargas, Benjamin A. Harlan, Kelby M. Killoy, Lauren Elizabeth Ball, Susana Comte‐Walters, Monika A. Gooz, Yasuhiko Yamamoto, Joseph S. Beckman, Luis Barbeito et al. · 2017 · Antioxidants and Redox Signaling
  39. Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
    Liaisan R. Arslanbaeva, Marco Bisaglia · 2022 · Molecules
  40. Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors
    Staffan Holmqvist, Marinka Brouwer, Mehdi Djelloul, Alejandro Garcia Diaz, Michael J. Devine, Anna Hammarberg, Karina Fog, Tilo Kunath, Laurent Roybon · 2015 · Stem Cell Research
  41. Progenitor cell-based treatment of glial disease
    Steven A. Goldman · 2017 · Progress in brain research
  42. Let’s make microglia great again in neurodegenerative disorders
    Marie‐Victoire Guillot‐Sestier, Terrence Town · 2017 · Journal of Neural Transmission
  43. Astroglial contribution to tau-dependent neurodegeneration
    Marta Sidoryk‐Wȩgrzynowicz, Lidia Strużyńska · 2019 · Biochemical Journal
  44. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Silvia Ravera, Tiziana Bonifacino, Martina Bartolucci, Marco Milanese, Elena Gallia, Francesca Provenzano, Katia Cortese, Isabella Panfoli, Giambattista Bonanno · 2018 · Molecular Neurobiology
  45. Neuronal–glial communication perturbations in murine SOD1G93A spinal cord
    Michael MacLean, Raquel López‐Díez, Carolina Vásquez, Paul F. Gugger, Ann Marie Schmidt · 2022 · Communications Biology
  46. Telomerase reverse transcriptase and neurodegenerative diseases
    Xin Yu, Mengmeng Liu, Caiyun Zheng, Yu‐Tong Liu, Zhuo Wang, Zhan-You Wang · 2023 · Frontiers in Immunology
  47. Amyloid oligomers: dynamics and toxicity in the cytosol and nucleus
    Akira Kitamura, Hiroshi Kubota · 2010 · FEBS Journal
  48. Decreased GLT‐1 and increased SOD1 and HO‐1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1‐G93A transgenic mice
    Yansu Guo, Weisong Duan, Zhongyao Li, Jing Huang, Yunxia Yin, Kunxi Zhang, Qian Wang, Zhifang Zhang, Chunyan Li · 2010 · FEBS Letters
  49. A Non-Specific Effect Associated with Conditional Transgene Expression Based on Cre-loxP Strategy in Mice
    Linghua Qiu, Jaime A. Rivera‐Pérez, Zuoshang Xu · 2011 · PLoS ONE
  50. Gene therapy for amyotrophic lateral sclerosis
    Thais Federici, Nicholas M. Boulis · 2011 · Neurobiology of Disease
  51. Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-κB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1 G93A mutation
    Xiang L. Yin, Shuyu Wang, Yan Qi, Xudong Wang, Hongquan Jiang, Tianhang Wang, Yueqing Yang, Ying Wang, Chun‐Ting Zhang, Honglin Feng · 2018 · Molecular and Cellular Neuroscience
  52. Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients
    Ovidiu C. Andronesi, Katharine A. Nicholson, Kourosh Jafari‐Khouzani, Wolfgang Bogner, Jing Wang, James Gin Man Chan, Eric A. Macklin, Mark Levine, Christopher T. Breen, Michael A. Schwarzschild et al. · 2020 · Frontiers in Neurology
  53. Could sirtuin activities modify ALS onset and progression?
    Tang, Bor Luen · 2017 · Cellular and Molecular Neurobiology
  54. Neuroprotective Role of the Basic Leucine Zipper Transcription Factor NFIL3 in Models of Amyotrophic Lateral Sclerosis
    So-ichi Tamai, Keisuke Imaizumi, Nobuhiro Kurabayashi, Minh Dang Nguyen, Takaya Abe, Masatoshi Inoue, Yoshitaka Fukada, Kamon Sanada · 2013 · Journal of Biological Chemistry
  55. Sirtuins as Modifiers of Huntington's Disease (HD) Pathology
    Sin Hui Neo, Bor Luen Tang · 2017 · Progress in molecular biology and translational science
  56. Mini-Review: Induced pluripotent stem cells and the search for new cell-specific ALS therapeutic targets
    Laura Ferraiuolo, Nicholas John Maragakis · 2021 · Neuroscience Letters
  57. Glial Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
    Patricia Cassina, Ernesto Miquel, Laura Martínez Palma, Adriana Cassina · 2021 · NeuroImmunoModulation
  58. Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
    Sarah M. Jacob, Suk‐young Lee, Seung Hyun Kim, Keith A. Sharkey, Gerald Pfeffer, Minh Dang Nguyen · 2024 · Nature Reviews Neurology
  59. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms
    Nicole Wächter, Alexander Storch, Andreas Hermann · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  60. Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
    Charlotte Veyrat‐Durebex, Philippe Corcia, Audrey Dangoumau, Frédéric Laumonnier, Éric Piver, P. H. Gordon, Christian Robert Andres, Patrick Vourc’h, Hélène Blasco · 2013 · Molecular Neurobiology
  61. Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
    Vincenzo Silani, Cinzia Calzarossa, Lidia Cova, Nicola Ticozzi · 2010 · CNS & Neurological Disorders - Drug Targets
  62. Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis
    Fang Fang, Honglei Chen, Karin Wirdefeldt, Lars‐Olof Ronnevi, Ammar Al‐Chalabi, Tracy L. Peters, Freya Kamel, Weimin Ye · 2011 · PLoS ONE
  63. Roles of glial cells in neuroinflammation and neurodegeneration
    Hideyuki Takeuchi · 2013 · Clinical and Experimental Neuroimmunology
  64. Human nasal olfactory epithelium as a dynamic marker for CNS therapy development
    Rita Sattler, Yoko Ayukawa, Luke T. Coddington, Akira Sawa, David Block, Richard E. Chipkin, Jeffrey D. Rothstein · 2011 · Experimental Neurology
  65. Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
    Lorelei Stoica, Miguel Sena‐Esteves · 2016 · Frontiers in Molecular Neuroscience
  66. Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
    Eiichi Tokuda, Itsuki Anzai, Takao Nomura, Keisuke Toichi, Masahiko Watanabe, Shinji Ohara, Seiji Watanabe, Koji Yamanaka, Yuta Morisaki, Hidemi Misawa et al. · 2017 · Molecular Neurodegeneration
  67. GDE2 is essential for neuronal survival in the postnatal mammalian spinal cord
    Clinton Cave, Sungjin Park, Marianeli Rodriguez, Mai Nakamura, Ahmet Höke, Mikhail V. Pletnikov, Shanthini Sockanathan · 2017 · Molecular Neurodegeneration
  68. The Legs at odd angles (Loa) Mutation in Cytoplasmic Dynein Ameliorates Mitochondrial Function in SOD1G93A Mouse Model for Motor Neuron Disease
    Ali Morsi El‐Kadi, Virginie Bros‐Facer, Wenhan Deng, Amelia Philpott, Eleanor Stoddart, Gareth T. Banks, Graham S. Jackson, Elizabeth Fisher, Michael R. Duchen, Linda Greensmith et al. · 2010 · Journal of Biological Chemistry
  69. The curious ways of ALS
    Magdalini Polymenidou, Don W. Cleveland · 2008 · Nature
  70. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
    Laura Rué, Patrick Oeckl, Mieke Timmers, Annette Lenaerts, Jasmijn van der Vos, Silke Smolders, Lindsay Poppe, Antina de Boer, Ludo Van Den Bosch, Philip Van Damme et al. · 2019 · Acta Neuropathologica Communications
  71. Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
    Ileana Lorenzini, Eric B. Alsop, Jennifer Levy, Lauren M. Gittings, Deepti Lall, Benjamin E. Rabichow, Stephen R. Moore, Ryan S. Pevey, Lynette M. Bustos, Camelia Burciu et al. · 2023 · Frontiers in Cellular Neuroscience
  72. mTOR Pathway – Novel Modulator of Astrocyte Activity
    Anna Latacz, John A. Russell, Ewa Anna Oclon, Joanna Zubel–Łojek, K Pierzchała · 2015 · Folia Biologica
  73. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1 transgenic mouse model of ALS
    Yasuhiro Yoshii, Asako Otomo, Lei Pan, Masato Ohtsuka, Shinji Hadano · 2011 · Neuroscience Research
  74. Human glial progenitor engraftment and gene expression is independent of the ALS environment
    Amanda M. Haidet-Phillips, Arpitha Doreswamy, Sarah K. Gross, Xiaopei Tang, James T. Campanelli, Nicholas John Maragakis · 2014 · Experimental Neurology
  75. Quantity and Activation of Myofiber-Associated Satellite Cells in a Mouse Model of Amyotrophic Lateral Sclerosis
    Raquel Manzano, Janne M. Toivonen, Ana Cristina Calvo, Sara Oliván, P. Zaragoza, Marı́a Jesús Muñoz, Didier Montarras, Rosario Osta · 2011 · Stem Cell Reviews and Reports
  76. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis
    Hongxia Lei, Elisabeth Dirren, Carole Poitry‐Yamate, Bernard Laurent Schneider, Rolf Gruetter A, Patrick Aebischer · 2018 · Journal of Cerebral Blood Flow & Metabolism
  77. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis
    Suk-Won Ahn, Gye Sun Jeon, Myung-Jin Kim, Jee-Heun Shon, Jee‐Eun Kim, Je-Young Shin, Sung‐Min Kim, Seung Hyun Kim, In-Hae Ye, Kwang Woo Lee et al. · 2014 · Journal of the Neurological Sciences
  78. Neuroglia: Functional Paralysis and Reactivity in Alzheimer’s Disease and Other Neurodegenerative Pathologies
    Alexei Verkhratsky, Robert Zorec, Jose Julio Rodriguez, Vladimir Parpura · 2017 · Advances in neurobiology
  79. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
    Aziza Alrafiah · 2018 · In Vivo
  80. Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis
    Carmen Rodríguez‐Cueto, Marta Gómez‐Almería, Laura García‐Toscano, Julián Romero, Cecilia J. Hillard, Eva de Lago, Javier Fernández‐Ruíz · 2021 · Brain Pathology
  81. SOD1 G93A Astrocyte-Derived Extracellular Vesicles Induce Motor Neuron Death by a miRNA-155-5p-Mediated Mechanism
    Soledad Marton, Ernesto Miquel, Joaquín Acosta-Rodríguez, Santiago Fontenla, Gabriela Libisch, Patricia Cassina · 2023 · ASN NEURO
  82. Expression of Microsomal Prostaglandin E Synthase-1 in the Spinal Cord in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
    Hiroko Miyagishi, Yasuhiro Kosuge, Kumiko Ishige, Yoshihisa Ito · 2012 · Journal of Pharmacological Sciences
  83. Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis
    Stephen A. Goutman, Kevin S. Chen, Eva L. Feldman · 2015 · Neurotherapeutics
  84. Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application
    Chen Benkler, Daniel Offen, Eldad Melamed, Lana Kupershmidt, Tamar Amit, Silvia A. Mandel, Moussa B. H. Youdim, Orly Weinreb · 2010 · The EPMA Journal
  85. PGC-1α Silencing Compounds the Perturbation of Mitochondrial Function Caused by Mutant SOD1 in Skeletal Muscle of ALS Mouse Model
    Yan Qi, Xiang L. Yin, Shuyu Wang, Hongquan Jiang, Xudong Wang, Ming Ren, Xiang-ping Su, Lei Shi, Honglin Feng · 2015 · Frontiers in Aging Neuroscience
  86. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Tiziana Bonifacino, Francesca Provenzano, Elena Gallia, Silvia Ravera, Carola Torazza, Simone Bossi, Sara Ferrando, Aldamaria Puliti, Ludo Van Den Bosch, Giambattista Bonanno et al. · 2019 · Neurobiology of Disease
  87. Chronic infusion of SOD1G93A astrocyte‐secreted factors induces spinal motoneuron degeneration and neuromuscular dysfunction in healthy rats
    Uri Nimrod Ramírez-Jarquín, Fabiola Rojas, Brigitte van Zundert, Ricardo Tapia · 2017 · Journal of Cellular Physiology
  88. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited
    Manuel José Rodríguez, Nicole Mahy · 2016 · Current Medicinal Chemistry
  89. Contributions of Drug Transporters to Blood-Brain Barriers
    Li Liu, Xiaodong Liu · 2019 · Advances in experimental medicine and biology
  90. Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
    Peng Wang, Yihong Ye · 2021 · Life
  91. Why should we care about astrocytes in a motor neuron disease?
    Katarina Stoklund Dittlau, Ludo Van Den Bosch · 2023 · Frontiers in Molecular Medicine
  92. Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase
    Jean‐Nicolas Audet, Genevíève Gowing, Renée Paradis, Geneviève Soucy, Jean‐Pierre Julien · 2012 · PLoS ONE
  93. Differential activation of neuronal and glial STAT 3 in the spinal cord of the SOD 1G93A mouse model of amyotrophic lateral sclerosis
    Tomohiro Ohgomori, Ryo Yamasaki, Hideyuki Takeuchi, Kenji Kadomatsu, Jun‐ichi Kira, Shozo Jinno · 2017 · European Journal of Neuroscience
  94. Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model
    Alida Spalloni, Viviana Greco, Giulia Ciriminna, Victor Corasolla Carregari, Federica Marini, Luisa Pieroni, Nicola Biagio Mercuri, Andrea Urbani, Patrizia Longone · 2019 · International Journal of Molecular Sciences
  95. Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function
    Arnaud Jacquier, Sarah Bellouze, Stéphane Blanchard, Delphine Bohl, Georg Haase · 2009 · Human Molecular Genetics
  96. Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7
    Anna F. Fusco, Logan A. Pucci, Pawel Michal Switonski, Debolina D. Biswas, Angela L. McCall, Amanda F. Kahn, Justin S. Dhindsa, Laura M. Strickland, Albert R. La Spada, Mai K. ElMallah · 2021 · Disease Models & Mechanisms
  97. CuATSM effectively ameliorates ALS patient astrocyte‐mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis
    Cassandra N. Dennys, Florence S. Roussel, Rochelle Rodrigo, Xiaojin Zhang, Julieth A. Sierra-Delgado, Annalisa M. Hartlaub, Asya Saelim‐Ector, Will Ray, Sarah Heintzman, Ashley Fox et al. · 2022 · Glia
  98. Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity
    Winanto Ng, Shi‐Yan Ng · 2022 · Translational Neurodegeneration
  99. The non-cell-autonomous component of ALS: new in vitro models and future challenges
    Laura Ferraiuolo · 2014 · Biochemical Society Transactions
  100. Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytes
    Milena M. Milosevic, Matjaž Stenovec, Marko Kreft, Vladimir Petrušić, Zorica Stević, Saša Trkov, Pavle R. Anđjus, Robert Zorec · 2013 · Cell Calcium